These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease. Höglund K; Wallin A; Blennow K Acta Neurol Scand Suppl; 2006; 185():87-92. PubMed ID: 16866916 [TBL] [Abstract][Full Text] [Related]
6. Cholesterol in Alzheimer's disease and tauopathy. Burns M; Duff K Ann N Y Acad Sci; 2002 Nov; 977():367-75. PubMed ID: 12480774 [TBL] [Abstract][Full Text] [Related]
7. The role of pleiotropic effects of statins in dementia. Crisby M Acta Neurol Scand Suppl; 2006; 185():115-8. PubMed ID: 16866920 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol and statins in Alzheimer's disease: current controversies. Fonseca AC; Resende R; Oliveira CR; Pereira CM Exp Neurol; 2010 Jun; 223(2):282-93. PubMed ID: 19782682 [TBL] [Abstract][Full Text] [Related]
9. Statins and their influence on brain cholesterol. Cibičková L J Clin Lipidol; 2011; 5(5):373-9. PubMed ID: 21981838 [TBL] [Abstract][Full Text] [Related]
10. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease. Treiber-Held S; Distl R; Meske V; Albert F; Ohm TG J Pathol; 2003 May; 200(1):95-103. PubMed ID: 12692847 [TBL] [Abstract][Full Text] [Related]
11. Re-assessing the relationship between cholesterol, statins and Alzheimer's disease. Wolozin B; Manger J; Bryant R; Cordy J; Green RC; McKee A Acta Neurol Scand Suppl; 2006; 185():63-70. PubMed ID: 16866913 [TBL] [Abstract][Full Text] [Related]
12. The conflicting role of brain cholesterol in Alzheimer's disease: lessons from the brain plasminogen system. Ledesma MD; Dotti CG Biochem Soc Symp; 2005; (72):129-38. PubMed ID: 15649137 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease: cholesterol a menace? Mathew A; Yoshida Y; Maekawa T; Kumar DS Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455 [TBL] [Abstract][Full Text] [Related]
14. Cholesterol in Alzheimer's disease and other amyloidogenic disorders. Harris JR; Milton NG Subcell Biochem; 2010; 51():47-75. PubMed ID: 20213540 [TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways. Silva T; Teixeira J; Remião F; Borges F Angew Chem Int Ed Engl; 2013 Jan; 52(4):1110-21. PubMed ID: 23280829 [TBL] [Abstract][Full Text] [Related]
16. Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function. Michikawa M Acta Neurol Scand Suppl; 2006; 185():21-6. PubMed ID: 16866907 [TBL] [Abstract][Full Text] [Related]
17. Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. Sierra S; Ramos MC; Molina P; Esteo C; Vázquez JA; Burgos JS J Alzheimers Dis; 2011; 23(2):307-18. PubMed ID: 21098985 [TBL] [Abstract][Full Text] [Related]
18. Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins. Pregelj P Psychiatr Danub; 2008 Jun; 20(2):162-7. PubMed ID: 18587285 [TBL] [Abstract][Full Text] [Related]